Willmott N, Chen Y, Goldberg J, Mcardle C, Florence A T
Department of Pharmacy, School of Pharmacy and Pharmacology, University of Strathclyde, Glasgow, UK.
J Pharm Pharmacol. 1989 Jul;41(7):433-8. doi: 10.1111/j.2042-7158.1989.tb06496.x.
The targeting and sustained release characteristics of cytotoxic drug-loaded protein microspheres may prove useful in the therapeutic chemoembolization of solid tumours. Because biodegradation rate of embolized particles will influence rate of incorporated drug release and duration of exposure, this parameter was studied for microspheres (10-30 microns mean diam.) prepared from the proteins albumin and casein, that we have previously used as carriers for doxorubicin. As a measure of microsphere loss in-vivo the radionuclide 125I was chosen because it can be covalently bound to proteins and also homogeneously distributed throughout the matrix. Radiolabelled microspheres were administered to rats both intravenously (lung as target organ, 1.4-2.2 mg/100 g) and via the hepatic artery (liver as target organ, 0.4-0.8 mg/100 g). In both cases it was observed that the casein system biodegraded more slowly than the albumin in-vivo. Thus, time taken for loss of 50% of embolized microspheres from lung was: albumin 2.0 days; casein 3.5 days and from liver:albumin 3.6 days; casein 6.8 days. Microsphere "debris" did not markedly accumulate in other organs. In-vitro experiments showed that microspheres were stable in serum and that albumin microspheres were not innately more sensitive to enzymic digestion than casein. The results may be useful in estimating duration of exposure of target organs to drug-loaded microsphere systems prepared from these proteins.
负载细胞毒性药物的蛋白质微球的靶向性和缓释特性可能在实体瘤的治疗性化疗栓塞中发挥作用。由于栓塞颗粒的生物降解速率会影响所含药物的释放速率和暴露持续时间,因此对由蛋白质白蛋白和酪蛋白制备的微球(平均直径10 - 30微米)进行了该参数的研究,我们之前曾将其用作阿霉素的载体。作为体内微球损失的一种衡量方法,选择了放射性核素125I,因为它可以与蛋白质共价结合,并且还能均匀分布在整个基质中。将放射性标记的微球静脉注射给大鼠(以肺作为靶器官,1.4 - 2.2毫克/100克)以及通过肝动脉注射(以肝作为靶器官,0.4 - 0.8毫克/100克)。在这两种情况下,均观察到酪蛋白系统在体内的生物降解比白蛋白更慢。因此,肺中栓塞微球损失50%所需的时间为:白蛋白2.0天;酪蛋白3.5天,而肝中:白蛋白3.6天;酪蛋白6.8天。微球“碎片”在其他器官中没有明显积累。体外实验表明微球在血清中稳定,并且白蛋白微球对酶消化的固有敏感性并不比酪蛋白更高。这些结果可能有助于估计靶器官对由这些蛋白质制备的负载药物微球系统的暴露持续时间。